TABLE 1.
Sample (n = 24) Mean (SD) or n (%) |
|
Age (years) | 49.8 (13.1) |
Sex (n) | |
Male/female | 5 (21)/19 (79) |
Occupation (n) | |
Employed/unemployed | 14 (58)/10 (42) |
Principal comorbidities (n) | |
Fibromyalgia | 5 (21) |
Hypertension | 4 (17) |
Enteric disease | 3 (12) |
Diabetes mellitus | 1 (4) |
Other rheumatic disease | 1 (4) |
None | 10 (42) |
Drug use (n) | |
Non-steroidal anti-inflammatory drugs | 5 (21) |
Antidepressants | 2 (8) |
Muscle relaxants | 2 (8) |
Analgesics | 3 (11) |
None | 12 (50) |
Symptoms duration (months) | 49.21 (68.59) |
Symptoms frequencies (n) | |
Continuous/episodic recurrent | 7 (35)/17 (65) |
Pain side (n) | |
Right/left/bilateral | 3 (10)/3 (15)/18 (75) |
Previous treatment | |
Physiotherapy | 11 (45) |
Arthrocentesis | 10 (35) |
Byte use | 16 (65) |
DC/TMD Axis I | |
Myofascial pain | 21 (90) |
Myalgia | 1 (5) |
Arthralgia | 2 (5) |
DC/TMD Axis II | |
Pain-related disability (n) | |
Low | 9 (37.5) |
High | 15 (62.5) |
Depression (n) | |
Minimal–mild | 16 (66.7) |
Moderate–severe | 8 (33.3) |
Anxiety (n) | |
Minimal–mild | 19 (79) |
Moderate–severe | 5 (21) |
Non-specific physical symptoms (n) | |
Minimal–mild | 13 (54) |
Moderate–high | 11 (46) |
NPRS | 6.42 (1.72) |
Catastrophizing (n) | |
Not present | 12 (50) |
Present | 12 (50) |
Central sensitization (n) | |
Subclinical–mild | 12 (50) |
Moderate–severe | 12 (50) |
n, number; SD, standard deviation; DC/TMD Axis I and Axis II, Diagnostic Criteria for Temporomandibular Disorders Axis I and Axis II; NPRS, Numeric Pain Rating Scale.